Stocks Explorer
Stocks
Sectors
Search
Valbiotis SAS(ALVAL) News
Profile
Chart
News
Analysis
ALVAL price today
by TradingView
Date
Title
Sep 11
VALBIOTIS SA: Valbiotis Presents the Full Results of the Phase II/III REVERSE-IT Study: Impressive Efficacy of TOTUM•63 Against Prediabetes and the Early Stages of Type 2 Diabetes, a First for a Non-drug Active Substance
‹ Prev
Page
of 1
Next ›